6 Recruiting Non-Alcoholic Fatty Liver Disease Phase 2 Clinical Trials
Active phase 2 studies for non-alcoholic fatty liver disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Non-Alcoholic Fatty Liver Disease studiesPhase 2 Studies for Non-Alcoholic Fatty Liver Disease
🔵 Active, Not Recruiting Phase2
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
📍 ProSciento CRU — Chula Vista, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
📍 The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149) — Chandler, Arizona
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
📍 Ann & Robert H Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase2
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
📍 Ann & Robert H Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2
Soluble Fibre Supplementation in NAFLD
📍 McMaster University Medical Center — Hamilton, Ontario
View Study & Checklist ➔